←
JIPO Editors1,825 posts
JIPO Editors avatar✓

JIPO Editors ✓

@JIPOEditors

JIPO is an open access, peer-reviewed journal dedicated to the field of #immunotherapy & #precisiononcology EiC: @ANaingMD @InnoJournals jipoonline.org

◷ Joined November 2017▧ 1,214 Photos and videos
JIPO Editors avatar
JIPO Editors@JIPOEditors·Nov 16

Immune checkpoint inhibitors have changed cancer treatment — but toxicity, resistance, and the lack of reliable predictive biomarkers continue to limit their impact. This landmark position paper by Hajjar et al. in #JIPO spans 93 pages, 50+ contributing authors from valued institutions like MD Anderson, and takes a comprehensive look at both where the field stands as well as where it needs to go. doi.org/10.36401/JIPO-26-12 @HajjarJoud @BettzyStephen @ajaysheshadri @kjazieh @ANaingMD @OncologyNetwork #PositionPaper #ICItherapy #irAEs #immunotherapy #precisiononcology #biomarkers #cancerresearch #JIPO

Post attachment
JIPO Editors avatar
JIPO Editors@JIPOEditors·Nov 10

ICI therapy works best when patients are referred early, yet many still arrive too late to benefit fully. Dr. Razelle Kurzrock addresses this gap in a new #JIPO commentary and video interview, making the case for early referral and precision strategies as the path forward in immune checkpoint inhibition. Article: doi.org/10.36401/JIPO-26-X6 Interview: youtu.be/-HxHLDwQ2Rg @Dr_R_Kurzrock @OncologyNetwork #ICItherapy #immunotherapy #precisiononcology #cancerresearch #JIPO